Yearbook of Cardiology 2017

Section 1: Coronary Heart Disease

Critical Journal Review

• Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function
• Outcomes in Women Better with Newer Generation Des
• When is Rotational Angiography Superior to Conventional Singleplane Angiography for Planning Coronary Angioplasty?
• Effects of Optimism and Gratitude on Physical Activity, Biomarkers, and Readmissions After an Acute Coronary Syndrome The Gratitude Research in Acute Coronary Events Study (GRACE study)
• Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease
• Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease-A Pairwise and Network Meta-
  Analysis
• Effect of Supplemental Oxygen Exposure on Myocardial Injury in ST-elevation Myocardial Infarction
• Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease
• Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction The ATLANTIC-H24 Analysis
• Successful Recanalization of Native Coronary Chronic Total Occlusion Is Not Associated With Improved Long-Term Survival
• Comparison of Early Versus Delayed Blockers in Acute Coronary Syndromes and Effect on Outcomes
• Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
• Drug Filled Polymer Free Stent Non-inferior to Conventional Drug Eluting Stent First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study
• Emergency Percutaneous Coronary Intervention in Post-Cardiac Arrest Patients without ST Segment Elevation Pattern: Insights from the PROCAT II Registry
• A Novel Score Predictive of Technical Failure During Percutaneous Coronary Revascularization for Chronic Total Occlusions
• PCI or CABG or Both Together? Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease
• Is Percutaneous Coronary Intervention (PCI) a Viable Option In Perioperative Myocardial nfarction (PMI)? Percutaneous Intervention for Myocardial Infarction after Noncardiac Surgery
• Pharmacodynamics Effects of Switching From Prasugrel to Ticagrelor: Results of Prospective Randomized SWAP 3 Study
• Early Invasive Treatment for NSTEMI-ACS Reduces Hospital Stay and Recurrent Ischemia But Not Death and MI: Timing of Coronary Invasive Strategy in Non-ST-segment Elevation Acute Coronary Syndrome and Clinical Outcomes
• Is Percutaneous Coronary Intervention Considered to be a Potential Alternative to Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis? Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease. 5-Year Outcomes of the PRECOMBAT Study
• Is It Time for Percutaneous Coronary Intervention for all Lesions in STEMI? Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous
  Coronary Intervention for STEMI and Multivessel Disease. The CvLPRIT Trial
• Does Operator Experience Play a Role in Outcomes after Left Main Percutaneous Coronary Intervention Impact of Operator Experience and Volume on Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention
• Does Percutaneous Coronary Intervention improve Outcomes in a patient with Multi-vessel Disease and Concurrent Chronic Total Occlusion? Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients with STEMI The EXPLORE Trial
• Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG
• When You Encounter Ectasia in Primary PCI: Risk Factors and Outcomes in Patients With Ectatic Infarct-related Artery Who Underwent Primary Percutaneous Coronary Intervention After ST Elevated Myocardial Infarction
• What is the Answer in Multivessel Disease? CABG or PCI? Long Term Mortality Revascularization In Nondiabetic Patients with Multivessel Disease
• Early Angiography could reduce Bleeding Events in Patients with non ST Segment Elevation  Acute Coronary Syndrome Bleeding Events Before Coronary Angiography in Patients With Non ST Segment Elevation Acute Coronary Syndrome
• When is the Right Time? Surgery post Coronary Drug Eluting Stent Implantation: Risk Associated With Surgery With 12 Months After Coronary Drug-Eluting Stent Implantation
• Is Aspiration Thrombectomy Really Associated with Increased Risk for Stroke? The Risk for Stroke With Aspiration Thrombectomy: Procedure or Patient Related? Insights From a Meta-Analysis
• Faster Drug Absorption, More Prompt and Potent Antiplatelet Effects: The New Crushed Prasugrel: Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention
• Safety and Efficacy Benefits of DCS over BMS in Patients With High Risk Of Bleeding 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents
• The EBC TWO Study (European Bifurcation Coronary TWO): A Randomized Comparison of Provisional T-Stenting Versus a Systematic 2 Stent Culotte Strategy in Large Caliber True
  Bifurcations
• Is Coronary Artery Bypass Graft Surgery Associated with Better Outcomes as Compared to Percutaneous Coronary Intervention? Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in Treatment of Unprotected Left Main Stenosis (Noble): A Prospective, Randomised, Open-label, Non-inferiority Trial
• The Evergreen Debate: PCI Versus Surgery in Unprotected Left Main CAD Coronary Artery Bypass
  Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease
• Left Internal Mammary Artery Versus Coronary Stents: Impact on Downstream Coronary Stenoses and Conduit Patency
• Repeat Revascularization more common after Percutaneous Coronary Intervention than after Coronary Artery Bypass Grafting Incidence, Characteristics, Predictors, and Outcomes of Repeat
  Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting The SYNTAX Trial at 5 Years
• Biocompatible Durable Polymer Coated Des Non Inferior to Biodegradable Polymer Des Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients with Coronary Artery Disease 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial
• Is there an ideal Level of Platelet P2Y12 Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention? Window Analysis from the ADAPT-DES Study
• Effect of Preoperative Aspirin Replacement With Enoxaparin in Patients Undergoing Primary Isolated on Pump CABG
• Perioperative Cardiovascular Risk of Prior Coronary Stent Implantation Among Patients Undergoing Non Cardiac Surgery
• A Randomized Comparison of Reservoir Based Polymer Free Amphilimus Eluting Stent Versus Everolimus Eluting Stent With Durable Polymer In Patients With Diabetes Mellitus
• The Association of Previous Revascularization with In-hospital Outcomes in Acute Myocardial Infarction Patients
• Post Hospital Outcomes of the Patients With Acute Myocardial Infarction With Cardiogenic Shock
• Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in The Pegasus-TIMI 54 Trial
• Impact of Access Site on Bleeding and Ischemic Effects in Patients With Nstemi Treated With Prasugrel
• Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug Elutng Stents
• Refining Echo Techniques for Left Ventricular Thrombus Detection Post-Myocardial Infarction
  Echocardiographic Algorithm for Post-Myocardial Infarction LV Thrombus: A Gatekeeper for Thrombus Evaluation by Delayed Enhancement CMR

Cardiology Currents

• Biodegradable Polymers versus Durable Polymers: Has the Jury Returned?
• High Sensitivity Troponins: Opportunities and Challenges
• When and Which Antiplatelet Drug Loading before PCI in Stable IHD?
• Fractional Flow Reserve Computed Tomography - Ready for Prime Time?
• Myocardial Viability Testing - Why and How?
• Serendipity from Noncardiac Imaging
• A Chronic Total Occlusion is Known by the Company it Keeps!
• Deferring Stenting in Primary PCI-What is the Last Word?
• Left Main Disease, Whos Baby is It Anyway?
• Management of Stable Ischemic Heart Disease - Current Perspective
• Dilemma - BMS or Des for Patients at High Bleeding Risk?
• Dilemma - Non St Elevation Myocardial Infarction: When to Intervene?
• Bioresorbable Scaffolds for Management of Coronary Bifurcation Lesions - Feasible?

Section 2: Noncoronary Heart Disease

Critical Journal Review

• Causes of Death in Anticoagulated Patients With Atrial Fibrillation
• Benefit of Vitamin K Antagonist Addition Anticoagulation Versus Antiplatelet or No Therapy In Patients Undergoing Bioprosthetic Valve Implantation: A Systematic Review and Meta-Analysis
• Age is the Culprit! Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry
• Importance of NOAC Optimum Dosing: Focus on ORBIT AF II Registry Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes. The ORBIT-AF II Registry
• Is Percutaneous Mitral Valve Plication Effective in Management of Severely Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
• Oral anticoagulation or Aspirin-What is Better? Aspirin Instead of Oral Anticoagulants Prescription in Atrial Fibrillation Patients at Risk for Stroke
• The Feminine Advantage: One Year Outcomes after TAVR Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy. TVT Registry From 2011 to 2014
• Feasibility Trial of Percutaneous Repair and Replacement Mitral Regurgitation Percutaneous Direct Annuloplasty. Lessons From an Early Feasibility Trial

Cardiology Currents

• Clearing Patients with Severe Aortic Stenosis for Non Cardiac Surgery
• The Value of Calcium in a Stenotic Aortic Valve
• Iron Therapy for Heart Failure-Intravenous or Oral?
• Atrial Fibrillation in STEMI Poor Prognosis: Determinants of Prognosis in Atrial Fibrillation in Acute ST-Elevation Myocardial Infarction (STEMI) and Acute Coronary Syndrome (ACS) -
  Arrhythmia or Comorbidities?
• Which New Oral Anticoagulant for Which Patient?

Section 3: Preventive Cardiology

Critical Journal Review

• Morning Home Blood Pressure is a Strong Predictor of Coronary Artery Disease: The HONEST Study
• Statins for Prevention of Cardiovascular Events in a Low-risk Population with Low Ankle Brachial Index
• Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
• The Association between Alcohol Abuse and Cardiac Disease
• Troponin Concentration Change at 1 year is Associated with Future Coronary Risk Independent of Cholesterol Lowering: High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease
• Influenza Vaccine for Prevention of MI: Influenza Vaccine as a Coronary Intervention for Prevention of Myocardial Infarction
• Are they Related: Social Relationships and Coronary Heart Disease? Loneliness and Social Isolation as Risk Factors for Coronary Heart Disease and Stroke: Systematic Review and Meta-Analysis of Longitudinal Observational Studies
• Tracking Plaque Regression with Statins on CCTA: Effects of Statin Therapy on Progression of Mild Noncalcified Coronary Plaque Assessed by Serial Coronary Computed Tomography Angiography: A Multicenter Prospective Study
• Importance of Intensive BP Control in Older Patients: Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients
• The Primary Drivers Of Changes In Preventive Medical And Lifestyle Practices Amongst People Presenting With Suspected Coronary Artery Disease: Changes in Medical Therapy and Lifestyle After Anatomical or Functional Testing for Coronary Artery Disease
• A New Weapon in the Prevention Armamentarium? Phosphodiesterase Type-5 Inhibitor Use in Type 2 Diabetes is Associated with a Reduction in All-cause Mortality
• Pulse Pressure and Risk of Cardiovascular Events in Patients With Atherothrombosis

Cardiology Currents

• Why Prevention is the Key to a Womans Heart?
• Statins for Primary Prevention - Widening the Net in Low-risk People. Narrowing it in High-risk People

Index